Instant Digital Pathology Global Market Report 2026

Instant digital pathology refers to highly automated, ultra-fast slide scanning technologies and digital microscopy systems that transform tissue specimens into high-resolution virtual slides for immediate digital evaluation and remote collaboration. Integrated with cloud-based platforms and artificial intelligence, these solutions enable pathologists to assess biopsy samples without delay, eliminating the need for physical slide transportation and accelerating critical cancer diagnosis.

The primary products of instant digital pathology include hardware, software, and storage systems. Hardware comprises digital pathology equipment, including whole-slide scanners and imaging devices, that capture, digitize, and process pathology specimens to enable rapid diagnostic assessment. These solutions support workflows such as scanning, image management, image analysis, and case sharing and reporting. Their major applications include disease diagnosis, drug discovery, academic research, and telepathology, while the principal end users are hospitals, diagnostic laboratories, research institutes, and pharmaceutical and biotechnology companies.

Tariffs are influencing the instant digital pathology market by increasing the expense of imported whole slide scanners, digital microscopy systems, high-resolution imaging components, and semiconductor-based hardware utilized in pathology workflows. This is raising procurement costs and influencing technology adoption, particularly in regions dependent on imported medical imaging equipment such as Asia-Pacific, Latin America, and emerging healthcare markets. Hardware-intensive categories including whole slide scanners, image capture devices, and workstation systems are experiencing greater effects because of global supply chain dependence. However, tariffs are also promoting local manufacturing, regional supplier diversification, and investment in domestic digital healthcare infrastructure, supporting long-term market resilience.

The instant digital pathology market research report is one of a series of new reports from The Business Research Company that provides instant digital pathology market statistics, including instant digital pathology industry global market size, regional shares, competitors with a instant digital pathology market share, detailed instant digital pathology market segments, market trends and opportunities, and any further data you may need to thrive in the instant digital pathology industry. This instant digital pathology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The instant digital pathology market size has grown rapidly in recent years. It will grow from $1.22 billion in 2025 to $1.44 billion in 2026 at a compound annual growth rate (CAGR) of 18.4%. The growth in the historic period can be attributed to increasing demand for faster cancer diagnosis, rising adoption of digital healthcare infrastructure, growing need for improved pathology workflow efficiency, increasing prevalence of chronic and oncology-related diseases, rising requirement for remote diagnostic capabilities.

The instant digital pathology market size is expected to see rapid growth in the next few years. It will grow to $2.85 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, growing demand for decentralized pathology services, rising need for enhanced diagnostic accuracy, increasing healthcare investment in advanced laboratory solutions, expanding use of virtual pathology consultation models. Major trends in the forecast period include increasing adoption of ultra-fast whole slide imaging systems for real-time pathology assessment, growing integration of remote pathology platforms for instant expert consultation and diagnosis, rising demand for automated tissue analysis workflows to reduce diagnostic turnaround time, increasing deployment of high-resolution digital microscopy solutions in pathology laboratories, growing preference for seamless interoperability between digital pathology systems and laboratory information systems.

The increasing adoption of digital pathology in clinical diagnostics is expected to drive the growth of the instant digital pathology market going forward. Digital pathology refers to the conversion of conventional glass microscope slides into high-resolution digital images through the use of whole-slide scanning technology. The adoption of digital pathology in clinical diagnostics is increasing due to the growing need for faster, more precise, and AI-enabled diagnostic workflows that enhance laboratory efficiency and reduce reporting turnaround times. Instant digital pathology supports rapid slide digitization, real-time image accessibility, AI-based analysis, and quicker clinical decision-making while reducing delays associated with traditional pathology processes. For instance, in January 2025, according to Labcorp, a US-based clinical laboratory and diagnostics company, approximately one-third (33%) of clinical laboratories had adopted whole-slide imaging, demonstrating the continued expansion of digital pathology adoption despite cost-related barriers. Therefore, the increasing adoption of digital pathology in clinical diagnostics is driving the growth of the instant digital pathology market.

Key companies operating in the instant digital pathology market are concentrating on developing high-throughput whole-slide scanners and advanced digital pathology platforms to enable rapid, high-resolution digitization of pathology slides. High-throughput whole-slide scanners quickly transform pathology slides into high-resolution digital images, enabling faster diagnosis and AI-assisted workflows. For example, in January 2025, Roche Diagnostics, a Switzerland-based diagnostics division of Roche Holding AG, received U.S. FDA 510(k) clearance for its VENTANA DP 600 high-volume slide scanner as part of the Roche Digital Pathology Dx system. The scanner enables instant high-resolution slide digitization, rapid whole-slide image acquisition, and accelerated digital pathology workflows, allowing pathologists to perform faster primary diagnoses and clinical decision-making. It is designed for high-throughput pathology laboratories, supporting continuous slide scanning with consistent image quality across large sample volumes. It integrates seamlessly with Roche's digital pathology software ecosystem, enabling efficient image management, case review, and collaboration among pathologists. By reducing manual slide handling and supporting AI-enabled image analysis applications, the system helps enhance laboratory productivity, diagnostic accuracy, and turnaround times.

In August 2025, Tempus AI, a US-based precision medicine and artificial intelligence company, acquired Paige for $81.25 million. Through this acquisition, Tempus AI sought to enhance its digital pathology and artificial intelligence capabilities by expanding its collection of clinically annotated pathology datasets, accelerating the creation of AI-driven diagnostic solutions, and advancing precision oncology applications to support improved clinical decisions. Paige is a US-based company specializing in AI-enabled digital pathology solutions that assist with cancer diagnosis, biomarker identification, and optimization of pathology workflows.

Major companies operating in the instant digital pathology market report are F. Hoffmann-La Roche Ltd., Leica Biosystems, Hamamatsu Photonics K.K., Koninklijke Philips N.V., Sectra AB, Epredia, Proscia Inc., Indica Labs Inc., Paige AI Inc., OptraSCAN Inc., Motic Digital Pathology, Ibex Medical Analytics Ltd., 3DHISTECH Ltd., Huron Digital Pathology Inc., Aiforia Technologies Plc, Lunit Inc., Inspirata Inc., Grundium Oy, PathPresenter Inc., Corista LLC, Morphle Labs Inc.

North America was the dominant region in the instant digital pathology market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the instant digital pathology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the instant digital pathology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The instant digital pathology market consists of revenues earned by entities by providing services such as digital slide scanning, image analysis, pathology workflow management, remote pathology consultation, artificial intelligence-assisted diagnostic support, cloud-based image storage, and system integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The instant digital pathology market also includes sales of dual wide-coverage computed tomography scanners, detector arrays, X-ray tubes, gantry systems, patient tables, high-voltage generators, collimators, slip ring assemblies, cooling systems and operator consoles designed for high-resolution volumetric diagnostic imaging. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Instant Digital Pathology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses instant digital pathology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for instant digital pathology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The instant digital pathology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Hardware; Software; Storage Systems
• 2) By Workflow: Scanning; Image Management; Image Analysis; Case Sharing And Reporting
• 3) By Application: Disease Diagnosis; Drug Discovery; Academic Research; Telepathology
• 4) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical And Biotechnology Companies
• Subsegments:
• 1) By Hardware: Whole Slide Scanners; Digital Microscopes; High Resolution Cameras; Image Capture Devices; Workstations And Display Monitors
• 2) By Software: Image Management Software; Image Analysis Software; Artificial Intelligence Assisted Diagnostic Software; Laboratory Information System Integration Software; Workflow Management Software
• 3) By Storage Systems: On Premises Storage; Cloud Based Storage; Hybrid Storage Solutions; Network Attached Storage; Storage Area Network
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Leica Biosystems; Hamamatsu Photonics K.K.; Koninklijke Philips N.V.; Sectra AB; Epredia; Proscia Inc.; Indica Labs Inc.; Paige AI Inc.; OptraSCAN Inc.; Motic Digital Pathology; Ibex Medical Analytics Ltd.; 3DHISTECH Ltd.; Huron Digital Pathology Inc.; Aiforia Technologies Plc; Lunit Inc.; Inspirata Inc.; Grundium Oy; PathPresenter Inc.; Corista LLC; Morphle Labs Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.